The Medical Advisor

We are pleased to announce that the first-of-its-kind protocol utilizing Ivermectin, Mebendazole, and Fenbendazole for cancer treatment has been peer-reviewed and officially published on September 19, 2024. Spearheaded by leading researchers like Dr. Ilyes Baghli, Dr. Pierrick Martinez, and the FLCCC’s Dr. Paul Marik, this groundbreaking protocol harnesses the untapped power of Ivermectin, Mebendazole, and Fenbendazole, known for their effectiveness against parasites. Now, these drugs are showing potential to battle cancer, marking the dawn of a new treatment evolution. This trio of repurposed drugs has been shown to disrupt the growth of cancer cells, particularly by targeting microtubules, the essential structures that allow cancer to multiply uncontrollably. What makes this protocol even more potent is the synergistic effect when these drugs are used together, creating a powerful new affordable weapon against cancer. Journal of Orthomolecular Medicine 2024 Targeting the Mitochondri...

DMSO and Cancer Note: this is part two of a three part series. In the third part of this series (which can be read here ), A Midwestern Doctor (AMD) explore how DMSO in combination with a natural dye creates a remarkable cancer treatment which safely treats a variety of otherwise challenging cancers. Because of the controversy surrounding DMSO, once its pioneers realised it also treated cancer, a decision was made to downplay this facet of DMSO as "unproven" cancer cures are always attacked by the medical system. As a result, DMSO's anticancer properties still remain relatively unknown. In  the first part of this series , I presented dozens of studies that show DMSO effectively treats cancer pain (which is often very challenging to address) and dramatically reduces many of the complications experienced from radiation therapy and chemotherapy (as it selectively protects healthy cells from those agents). Given how debilitating each of those can be for a cancer patient, it i...